Developer docs
API playgroundTry for free, no card

Search company profiles

HealthQuad

Full company profile

uuid0000bve

Namestring
HealthQuad
Legal namestring
Healthquad Advisors Private Limited
Websiteurl
healthquad.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

HealthQuad is a healthcare-focused venture capital firm founded in 2016 and headquartered in India, operating as the early-growth investment arm of Quadria Capital. The firm invests in growth-stage healthcare companies across India, Southeast Asia, and GCC markets, with assets under management exceeding $400M and a portfolio of more than 18 companies spanning healthcare delivery, diagnostics, digital health, medical devices, and emergency response logistics.

The firm's core differentiator is operating expertise: a 20+ member team with over 200 years of collective clinical experience supports proprietary deal sourcing, due diligence, and post-investment value creation. HealthQuad leverages Asia's largest healthcare investment network — including co-investment partners, hospital chains, and clinical advisors — to access off-market opportunities and assist portfolio companies with clinical partnerships, regulatory navigation, and follow-on capital. Recent investments include participation in Qure.ai's $65M Series D (AI-driven diagnostics), Red.Health's $20M Series B (emergency response logistics), and LifeSigns (connected medical devices), indicating a deliberate tilt toward technology-enabled and AI-enabled healthcare models.

HealthQuad's revenue model is the standard alternative asset manager construct: recurring management fees (typically 1.5–2.0% of committed/invested AUM) provide baseline revenue, while performance-based carried interest on realized exits supplements income episodically. The firm raised Fund III with a $55M first close in June 2026, positioning it to expand its pan-Asian mandate. Its LP base spans fund-of-funds, institutional investors, and family offices, and in 2025 HealthQuad completed a mutual separation from KOIS, repositioning the brand as an independent entity within the Quadria ecosystem.

Short descriptiontext

HealthQuad is an India-based healthcare-focused venture capital firm founded in 2016, operating as Quadria Capital's early-growth arm. It invests in growth-stage healthcare companies across India and Asia, managing over $400M in AUM across 18+ portfolio companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare venture capital, venture capital funds, healthtech investing, medtech investment, biopharma venture capital
Industry2 codes
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Venture Capital / Private Equity Fund Management
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Fund Management Fees
TypeManaged Services
Description

Recurring management fees earned on capital commitments across three Category I/II Alternative Investment Funds (HealthQuad Fund I, HealthQuad Fund II, HealthQuad Trust III) registered with SEBI. Fund managers are Healthquad Advisors Private Limited and Healthquad Capital Advisors Private Limited.

healthquad.com
2Investment Returns / Carried Interest
TypeLicensing Royalties
Description

Returns generated from equity stakes in portfolio companies and successful exits; Group claims 16 exits across 38 investments. Fund I delivered 3X returns. The firm earns carried interest on realized profits above the preferred return hurdle.

yourstory.com
3Capital Gains from Portfolio Exits
TypeTransaction Fee
Description

One-time and ongoing capital gains realized from partial or full exits of portfolio companies such as Medikabazaar (partially exited), AINU, Strand Life Sciences, Regency Health, and Hi Impact.

qure.ai
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

HealthQuad is a healthcare-focused venture capital fund manager that pools institutional capital from limited partners via three SEBI-registered Alternative Investment Funds (HealthQuad Fund I, Fund II, and Fund III) and deploys it as equity investments into early-growth healthcare companies. Operating as the early-growth arm of Quadria Capital, the firm invests across four segments — HealthTech, MedTech, Bio/PharmTech, and novel healthcare delivery — with USD 30–50 million ticket sizes, while providing portfolio companies hands-on value creation support across sourcing, execution, scaling, and exit.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • USD 400M+ in AUM across three funds
+5 more records
Product overview1 text field

HealthQuad's offering is a single unified venture capital investment platform — not a multi-module SaaS product — operated as the early-growth arm of Quadria Capital and structured around three registered SEBI funds: HealthQuad Fund I (Category I Venture Capital Fund, IN/AIF1/16-17/0216), HealthQuad Fund II (Category II AIF, IN/AIF2/19-20/0684), and HealthQuad Fund III (Category II AIF, IN/AIF2/23-24/1445). These three funds together constitute HealthQuad's core product set, channeling capital from LPs (fund-of-funds, institutions, family offices) into technology-enabled healthcare companies across HealthTech, MedTech, Bio/PharmTech, and novel healthcare delivery models, with a pan-Asian footprint spanning India, Singapore, Indonesia, and Vietnam.

Product and service4 records
1HealthQuad Fund I
CategoryVenture capital fund (Category I AIF)
Description

Category I – Venture Capital Fund (SEBI Registration No. IN/AIF1/16-17/0216) managed by Healthquad Advisors Private Limited; the firm's first healthcare-focused venture fund backing early-stage healthcare companies in India.

2HealthQuad Fund II
CategoryAlternative investment fund (Category II AIF)
Description

Category II Alternative Investment Fund (SEBI Registration No. IN/AIF2/19-20/0684) managed by Healthquad Capital Advisors Private Limited; the firm's second healthcare-focused fund backing tech-enabled growth-stage healthcare companies.

3HealthQuad Fund III
CategoryAlternative investment fund (Category II AIF)
Description

Category II AIF (SEBI Registration No. IN/AIF2/23-24/1445) managed by Healthquad Advisors Private Limited; the firm's third and current fund with INR 1,700 crore target corpus (expandable to INR 2,500 crore), focusing on early-growth investments with USD 30–50 million tickets across HealthTech, MedTech, Bio/Pharma Tech, and novel healthcare delivery. First investment: LifeSigns.

4HealthQuad Healthcare Venture Capital Platform
CategoryInvestment platform (core offering)
Description

Asia's leading healthcare-focused venture capital investment platform operated as the early-growth arm of Quadria Capital; pools institutional capital via the three HealthQuad Funds and deploys into new-age healthcare companies across Healthtech, Medtech, Novel Healthcare Delivery, and Bio/Pharmtech, offering portfolio companies strategic support across origination, execution, value creation, amplification, and realization.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

India-focused venture firm with healthcare investments across healthtech and medtech. Comparable as a category-leading India VC that competes for the same early-growth healthcare founders.

TypeBroad incumbent
Description

Parent platform of HealthQuad and one of Asia's largest healthcare-focused PE firms with $4B+ AUM. Directly comparable as a healthcare-dedicated capital provider in India and Asia, though focused on growth/control buyouts versus HealthQuad's early-growth venture strategy.

TypeBroad incumbent
Description

India's largest homegrown PE firm with growing healthcare exposure across pharma, hospitals, and healthtech. Comparable as a pan-Asia investor with healthcare vertical depth, though it operates more broadly across sectors and at larger ticket sizes.

TypeBroad incumbent
Description

Global venture and growth equity firm with an active India healthcare practice, investing across healthtech, medtech, and healthcare services. Directly comparable as a growth-stage healthcare investor serving Indian and Asian founders.

TypeBroad incumbent
Description

India's largest VC firm with deep healthtech exposure (Innovaccer, others) and a healthcare-dedicated practice. Comparable as a leading India VC with growing healthcare vertical depth competing for the same founder pool.

TypeRegional player
Description

India-focused impact investment advisor active in healthcare and education. Comparable as a regional capital partner targeting healthcare access and affordability themes across India, intersecting with HealthQuad's impact mandate.

7Leverage Innovation Ventures (LIV) / Dr. M.J. Bhatt healthcare funds
TypeEmerging player
Description

Emerging India-focused healthcare venture funds targeting similar early-stage healthtech and provider-services opportunities. Comparable as niche healthcare-dedicated funds competing for similar deal flow in India's healthtech ecosystem.

TypeOthers
Description

Former strategic partner of HealthQuad/Quadria Group before the 2025 mutual separation. Comparable historically as a co-investor and co-platform in Asia healthcare impact investing; relevant as the prior shareholder relationship that just concluded.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment32 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HealthQuad

Healthcare Venture Capital / Private Equity Fund Managementhealthquad.com

HealthQuad is an India-based healthcare-focused venture capital firm founded in 2016, operating as Quadria Capital's early-growth arm. It invests in growth-stage healthcare companies across India and Asia, managing over $400M in AUM across 18+ portfolio companies.

What HealthQuad does

HealthQuad is a healthcare-focused venture capital firm founded in 2016 and headquartered in India, operating as the early-growth investment arm of Quadria Capital. The firm invests in growth-stage healthcare companies across India, Southeast Asia, and GCC markets, with assets under management exceeding $400M and a portfolio of more than 18 companies spanning healthcare delivery, diagnostics, digital health, medical devices, and emergency response logistics.

The firm's core differentiator is operating expertise: a 20+ member team with over 200 years of collective clinical experience supports proprietary deal sourcing, due diligence, and post-investment value creation. HealthQuad leverages Asia's largest healthcare investment network — including co-investment partners, hospital chains, and clinical advisors — to access off-market opportunities and assist portfolio companies with clinical partnerships, regulatory navigation, and follow-on capital. Recent investments include participation in Qure.ai's $65M Series D (AI-driven diagnostics), Red.Health's $20M Series B (emergency response logistics), and LifeSigns (connected medical devices), indicating a deliberate tilt toward technology-enabled and AI-enabled healthcare models.

HealthQuad's revenue model is the standard alternative asset manager construct: recurring management fees (typically 1.5–2.0% of committed/invested AUM) provide baseline revenue, while performance-based carried interest on realized exits supplements income episodically. The firm raised Fund III with a $55M first close in June 2026, positioning it to expand its pan-Asian mandate. Its LP base spans fund-of-funds, institutional investors, and family offices, and in 2025 HealthQuad completed a mutual separation from KOIS, repositioning the brand as an independent entity within the Quadria ecosystem.

HealthQuad firmographics

Firmographics
Name
HealthQuad
Legal name
Healthquad Advisors Private Limited
Website
https://healthquad.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
HealthQuad is an India-based healthcare-focused venture capital firm founded in 2016, operating as Quadria Capital's early-growth arm. It invests in growth-stage healthcare companies across India and Asia, managing over $400M in AUM across 18+ portfolio companies.
Ownership category
akta.pro rank

HealthQuad industry classification

Industry
Product category
Healthcare Venture Capital / Private Equity Fund Management
NAICS
Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds

Keywords

  • Healthcare venture capital
  • Venture capital funds
  • Healthtech investing
  • Medtech investment
  • Biopharma venture capital

Where HealthQuad is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices1 record

Markets served

HealthQuad business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Fund Management Fees: Recurring management fees earned on capital commitments across three Category I/II Alternative Investment Funds (HealthQuad Fund I, HealthQuad Fund II, HealthQuad Trust III) registered with SEBI. Fund managers are Healthquad Advisors Private Limited and Healthquad Capital Advisors Private Limited.
  2. Investment Returns / Carried Interest: Returns generated from equity stakes in portfolio companies and successful exits; Group claims 16 exits across 38 investments. Fund I delivered 3X returns. The firm earns carried interest on realized profits above the preferred return hurdle.
  3. Capital Gains from Portfolio Exits: One-time and ongoing capital gains realized from partial or full exits of portfolio companies such as Medikabazaar (partially exited), AINU, Strand Life Sciences, Regency Health, and Hi Impact.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

HealthQuad product offering

Product offering

Core offering

HealthQuad is a healthcare-focused venture capital fund manager that pools institutional capital from limited partners via three SEBI-registered Alternative Investment Funds (HealthQuad Fund I, Fund II, and Fund III) and deploys it as equity investments into early-growth healthcare companies. Operating as the early-growth arm of Quadria Capital, the firm invests across four segments — HealthTech, MedTech, Bio/PharmTech, and novel healthcare delivery — with USD 30–50 million ticket sizes, while providing portfolio companies hands-on value creation support across sourcing, execution, scaling, and exit.

Product overview

HealthQuad's offering is a single unified venture capital investment platform — not a multi-module SaaS product — operated as the early-growth arm of Quadria Capital and structured around three registered SEBI funds: HealthQuad Fund I (Category I Venture Capital Fund, IN/AIF1/16-17/0216), HealthQuad Fund II (Category II AIF, IN/AIF2/19-20/0684), and HealthQuad Fund III (Category II AIF, IN/AIF2/23-24/1445). These three funds together constitute HealthQuad's core product set, channeling capital from LPs (fund-of-funds, institutions, family offices) into technology-enabled healthcare companies across HealthTech, MedTech, Bio/PharmTech, and novel healthcare delivery models, with a pan-Asian footprint spanning India, Singapore, Indonesia, and Vietnam.

Differentiator

Problem solved

Functional benefit

Products and services

  • HealthQuad Fund I Category I – Venture Capital Fund (SEBI Registration No. IN/AIF1/16-17/0216) managed by Healthquad Advisors Private Limited; the firm's first healthcare-focused venture fund backing early-stage healthcare companies in India.
  • HealthQuad Fund II Category II Alternative Investment Fund (SEBI Registration No. IN/AIF2/19-20/0684) managed by Healthquad Capital Advisors Private Limited; the firm's second healthcare-focused fund backing tech-enabled growth-stage healthcare companies.
  • HealthQuad Fund III Category II AIF (SEBI Registration No. IN/AIF2/23-24/1445) managed by Healthquad Advisors Private Limited; the firm's third and current fund with INR 1,700 crore target corpus (expandable to INR 2,500 crore), focusing on early-growth investments with USD 30–50 million tickets across HealthTech, MedTech, Bio/Pharma Tech, and novel healthcare delivery. First investment: LifeSigns.
  • HealthQuad Healthcare Venture Capital Platform Asia's leading healthcare-focused venture capital investment platform operated as the early-growth arm of Quadria Capital; pools institutional capital via the three HealthQuad Funds and deploys into new-age healthcare companies across Healthtech, Medtech, Novel Healthcare Delivery, and Bio/Pharmtech, offering portfolio companies strategic support across origination, execution, value creation, amplification, and realization.

Quantifiable outcome

  • USD 400M+ in AUM across three funds
  • +5 more outcomes

Companies that use HealthQuad

Customer profile

Segments6 records

Ideal customer profiles2 records

HealthQuad technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

HealthQuad partnerships and signals

Strategic signal

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

HealthQuad competitors and assessment

Company assessment

Broad incumbents

  • Accel India: India-focused venture firm with healthcare investments across healthtech and medtech. Comparable as a category-leading India VC that competes for the same early-growth healthcare founders.
  • Quadria Capital: Parent platform of HealthQuad and one of Asia's largest healthcare-focused PE firms with $4B+ AUM. Directly comparable as a healthcare-dedicated capital provider in India and Asia, though focused on growth/control buyouts versus HealthQuad's early-growth venture strategy.
  • ChrysCapital: India's largest homegrown PE firm with growing healthcare exposure across pharma, hospitals, and healthtech. Comparable as a pan-Asia investor with healthcare vertical depth, though it operates more broadly across sectors and at larger ticket sizes.
  • Norwest Venture Partners India: Global venture and growth equity firm with an active India healthcare practice, investing across healthtech, medtech, and healthcare services. Directly comparable as a growth-stage healthcare investor serving Indian and Asian founders.
  • Peak XV Partners (formerly Sequoia Capital India): India's largest VC firm with deep healthtech exposure (Innovaccer, others) and a healthcare-dedicated practice. Comparable as a leading India VC with growing healthcare vertical depth competing for the same founder pool.

Regional players

Emerging players

  • Leverage Innovation Ventures (LIV) / Dr. M.J. Bhatt healthcare funds: Emerging India-focused healthcare venture funds targeting similar early-stage healthtech and provider-services opportunities. Comparable as niche healthcare-dedicated funds competing for similar deal flow in India's healthtech ecosystem.

Others

  • KOIS (Kois Invest / Belgium-based impact investor): Former strategic partner of HealthQuad/Quadria Group before the 2025 mutual separation. Comparable historically as a co-investor and co-platform in Asia healthcare impact investing; relevant as the prior shareholder relationship that just concluded.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

HealthQuad social profiles

Digital presence

HealthQuad financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HealthQuad leadership team

Management profile

Number of profiles

Profiles8 records

HealthQuad subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

HealthQuad funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HealthQuad M&A and investment

M&A and investment

M&A

Investments32 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HealthQuad

What does HealthQuad do?

HealthQuad is a healthcare-focused venture capital fund manager that pools institutional capital from limited partners via three SEBI-registered Alternative Investment Funds (HealthQuad Fund I, Fund II, and Fund III) and deploys it as equity investments into early-growth healthcare companies. Operating as the early-growth arm of Quadria Capital, the firm invests across four segments — HealthTech, MedTech, Bio/PharmTech, and novel healthcare delivery — with USD 30–50 million ticket sizes, while providing portfolio companies hands-on value creation support across sourcing, execution, scaling, and exit.

Is HealthQuad a public or private company?

HealthQuad is a private company. It is classified as private equity controlled and is currently operating.

When was HealthQuad founded?

HealthQuad was founded in 2016. It employs 11 to 50 people.

Where is HealthQuad based?

HealthQuad is headquartered in New Delhi, India, in the Asia region.

How does HealthQuad make money?

Three revenue lines are on record. Fund Management Fees are the primary driver. The others are investment Returns / Carried Interest and capital Gains from Portfolio Exits.

Who are HealthQuad's main competitors?

Broad incumbents on record are Accel India, Quadria Capital, ChrysCapital, Norwest Venture Partners India and Peak XV Partners (formerly Sequoia Capital India). Impact Investors Council / Unitus Capital healthcare funds is listed as a regional player. Leverage Innovation Ventures (LIV) / Dr. M.J. Bhatt healthcare funds is listed as an emerging player. KOIS (Kois Invest / Belgium-based impact investor) is listed as an others.

Does HealthQuad have an API?

No public API is recorded for HealthQuad.

What industry is HealthQuad in?

HealthQuad's product category is Healthcare Venture Capital / Private Equity Fund Management. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANAJAI, Healthcare Access & Life Sciences Impact Funds. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerIndia’s healthcare infrastructure becoming AI-readyBain & Company and HealthQuad report that Indian healthcare providers are shifting AI from experimental to real-world applications, with remote monitoring and ICU optimization as key opportunities. EMR adoption stands at 35%, and frontier model costs have fallen 92% since 2023. The report warns that early movers will widen the gap as hospitals build data foundations.Business StandardAI application in Indian healthcare rising but adoption uneven: ReportA joint Bain & HealthQuad report on AI in Indian healthcare delivery found adoption uneven across hospitals, with most still testing AI in controlled settings. EMR adoption is estimated at about 35%, and clinical AI is emerging mainly among digitally mature providers. The report recommends treating AI as a business transformation rather than an IT project.YourStoryAI in healthcare: Remote monitoring, ICU optimisation to be next growth frontiers, says reportA joint report by Bain & Company and HealthQuad says AI in Indian healthcare will next focus on remote monitoring, ICU optimization, and post-discharge chronic disease management. It notes a 35% EMR adoption rate limits connected clinical care, while AI's autonomous work capacity has doubled every 6-9 months since 2023 and model costs fell 92%.Business StandardAI in healthcare: Remote monitoring next growth frontier, says reportA joint report by Bain & Company and HealthQuad identified remote patient monitoring, OT/ICU optimization, and post-discharge chronic disease management as the next AI growth frontier in Indian healthcare. It notes a 35% EMR adoption rate limits connected clinical care, while AI's autonomous work capacity has doubled every 6-9 months since 2023.https://www.outlookbusiness.com/AI In Healthcare: Remote Monitoring, ICU Optimisation To Be Next Growth Frontiers, Says Report – Outlook BusinessA joint report by Bain & Company and HealthQuad says AI in Indian healthcare will next focus on remote monitoring, ICU optimization, and post-discharge chronic disease management. It notes a 35% EMR adoption rate limits connected clinical care, while AI's autonomous work has doubled every 6-9 months since 2023 and model costs fell 92%.IndiaWeb2AI Infrastructure in Indian Healthcare: Bain & HealthQuad Spotlight Tech‑Driven TransformationBain & Company and HealthQuad released a report on AI adoption in Indian healthcare, finding that operational use cases are scaling first while clinical applications remain limited. EMR adoption stands at about 35%, and frontier AI model costs have fallen roughly 92% since 2023. The report identifies remote patient monitoring and ICU optimization as key growth areas.EntrackrFunding and acquisitions in Indian startups this week [June 15 - June 20]Indian startups raised nearly $432 million across 21 disclosed deals this week, including 7 growth-stage and 14 early-stage rounds. AI startup Sarvam led with a $234 million Series B at a $1.5 billion valuation, while funding surged 70.5% year-on-year. The week also saw a new unicorn, 10 leadership hires, and a L'Oréal acquisition.Business News TodayQuadria-backed HealthQuad secures Rs 550 crore for Fund III amid healthcare tech boomHealthQuad, backed by Quadria Capital, has secured Rs 550 crore for its third fund (Fund III) to invest in the healthcare technology sector. This capital raise comes amid a broader boom in healthcare tech investments.Entrepreneur IndiaHealthQuad Announces First Close Commitments for Fund IIIHealthQuad, a healthcare-focused investor backed by Quadria Group, announced first close commitments of INR 550 crores for HealthQuad Fund III, representing over one-third of its INR 1,700 crore target size. The fund has made its first investment in Lifesigns, an AI-powered remote patient monitoring platform in India, with commitments coming from existing and new limited partners including fund of funds, institutions, and family offices. Fund III is a successor to HealthQuad Funds I and II, which collectively backed over 18 healthcare companies including GoApptiv, Qure.ai, Redcliffe Labs, and Medikabazaar.Digital Health NewsHealthQuad Reaches First Close of Fund III with INR 550 Cr to Accelerate India's Digital Health InnovationHealthQuad, a venture capital firm, has completed the first close of its Fund III by raising INR 550 Cr, with investments focused on early-growth startups in digital health sectors in India. The fund aims to support innovations in healthtech, medtech, biopharma, and healthcare delivery, with its first investment made in an AI-powered remote patient monitoring platform.